The Symposium was a great
opportunity to exchange medical experience and raising the awareness of the
ongoing unmet medical need in COPD among the professors and the audience. The
Symposium concluded that Broncho-Vaxom® is an effective prophylactic measure
widely used by Pulmonologists in the field of respiratory diseases as it
stimulates the immune system and the body’s natural defence against a wide
spectrum of respiratory pathogens.
-So that, The prevention of COPD exacerbations with
Broncho-Vaxom can decrease symptoms,
the number and the severity of exacerbations, thus modifying the
natural course of the disease and costs.